Strong Sales Growth in Key Segments
Hearing Instruments and Audiological Care saw a combined sales growth of 7% in local currencies, which is around twice the estimated market growth, resulting in significant market share gains.
Record Earnings and Margin Expansion
Normalized EBITA reached CHF 316 million, up 16% in local currencies, leading to a strong margin expansion of 180 basis points.
Successful Product Launches
The launch of Phonak Infinio and Infinio Sphere platforms and the new Virto R rechargeable hearing device received strong market responses, contributing positively to growth.
Positive Outlook and Market Share Gains
Sonova maintains its outlook for the fiscal year 2025-2026, targeting 5% to 9% sales growth and 14% to 18% growth in normalized EBITA at constant exchange rates.